2.A New Onset of Systemic Lupus Erythematosus Developed After Bee Venom Therapy.
Young Hee RHO ; Jin Hyun WOO ; Seong Jae CHOI ; Young Ho LEE ; Jong Dae JI ; Gwan Gyu SONG
The Korean Journal of Internal Medicine 2009;24(3):283-285
Lupus is a systemic autoimmune disease of an unknown origin, and systemic lupus erythematosus (SLE) can be triggered by numerous stimuli. Bee venom therapy is an alternative therapy that is believed to be effective for various kinds of arthritis. We present here a case of a 49-year-old female who experienced a new onset lupus after undergoing bee venom therapy, and this looked like a case of angioedema. The patient was successfully treated with high dose steroids and antimalarial drugs. We discuss the possibility of bee venom contributing to the development of SLE, and we suggest that such treatment should be avoided in patients with lupus.
Bee Venoms/*adverse effects
;
Female
;
Humans
;
Lupus Erythematosus, Systemic/*etiology/pathology
;
Middle Aged
3.Spinal processing of bee venom-induced pain and hyperalgesia.
Acta Physiologica Sinica 2008;60(5):645-652
Subcutaneous injection of bee venom causes long-term neural activation and hypersensitization in the dorsal horn of the spinal cord, which contributes to the development and maintenance of various pain-related behaviors. The unique behavioral 'phenotypes' of nociception and hypersensitivity identified in the rodent bee venom test are believed to reflect a complex pathological state of inflammatory pain and might be appropriate to the study of phenotype-based mechanisms of pain and hyperalgesia. In this review, the spinal processing of the bee venom-induced different 'phenotypes' of pain and hyperalgesia will be described. The accumulative electrophysiological, pharmacological, and behavioral data strongly suggest that different 'phenotypes' of pain and hyperalgesia are mediated by different spinal signaling pathways. Unraveling the phenotype-based mechanisms of pain might be useful in development of novel therapeutic drugs against complex clinic pathological pain.
Animals
;
Bee Venoms
;
adverse effects
;
Hyperalgesia
;
physiopathology
;
Pain
;
physiopathology
;
Rats
;
Rats, Sprague-Dawley
;
Spinal Cord
;
physiology
4.A case of subacute liver failure resulted from bee venom.
Shan ZHONG ; Zhi ZHOU ; You-rong ZHAO ; Qiang LUO ; Hong REN
Chinese Journal of Hepatology 2005;13(11):827-831
5.Efficacy of Bee Venom Injection for Osteoarthritis Patients.
Choong Hee WON ; Eui Seong CHOI ; Seong Sun HONG
The Journal of the Korean Rheumatism Association 1999;6(3):218-226
OBJECTIVES: Bee venom contains a potent antiinflammatory peptide 401 as well as mellitin. The purpose of this study was to see the efficacy and safety of purified bee venom injection therapy for knee or spinal osteoarthritis patients. METHODS: One hundred and one osteoarthritis patients were randomly assigned to bee venom injection therapy or oral nabumetone medication group. Bee venom injection group was subdivided into 3 groups according to different dosing schedule(group A: gradual increase up to 0.7mg, group B: up to 1.5mg and group C: up to 2.0mg). Control group patients(group D) were given 1000mg nabumetone daily for 6 weeks. There were 25, 26, 25, and 26 patients assigned to A, B, C, or D group. The efficacy of treatment was evaluated by measuring instruments developed by authors, and the safety of bee venom injection was evaluated by hematology and chemistry laboratory examination. RESULTS: Among 101 patients, eighty-one patients completed the study, but twenty patients were dropped out and two of these patients were dropped out due to adverse drug reaction. The efficacy in bee venom group showed better improvement than nabumetone group(p<0.01). Within bee venom group, group B and C showed better improvement than group A(p<0.01). Itching around injection site occurred in most patients, and bodyache occurred in 49 patients (81.7%). Hemoglobin was decreased(0.3g/dl) in group C, but no significant changes were observed in other laboratory values. CONCLUSION: The efficacy of bee venom injection in the control of knee or back pain in osteoarthritis patients was better than nabumetone medication. No severe allergic or adverse reaction was observed in bee venom treatment patients, but problems related with bee venom injection, such as pruritis, bodyache, and the possibility of anaphylaxis, should be considered for the use of bee venom injection.
Anaphylaxis
;
Back Pain
;
Bee Venoms*
;
Bees*
;
Chemistry
;
Drug-Related Side Effects and Adverse Reactions
;
Hematology
;
Humans
;
Knee
;
Melitten
;
Osteoarthritis*
;
Osteoarthritis, Spine
;
Pruritus
6.Use of sIgE/T-IgE in Predicting Systemic Reactions: Retrospective Analysis of 54 Honeybee Venom Allergy Cases in North China.
Kai GUAN ; Li-Sha LI ; Jia YIN
Chinese Medical Journal 2016;129(17):2091-2095
BACKGROUNDVenom allergy is significantly underestimated in China. Venom-specific IgE may not provide accurate clinical reactions. Our conducted retrospective analysis observes alternative diagnostic considerations in assessing confirmation and severity of honeybee venom allergy.
METHODSRetrospective review of honeybee venom allergy versus nonallergy patients presented with positive honeybee venom (i1) sIgE results. According to clinically observed reactions caused by a honeybee sting, patients were divided into three groups. Patient residence and exposure types were analyzed. The sIgE/T-IgE among allergy and control groups was compared.
RESULTSGender ratio male:female was 32:22; median age was 39 years (31, 50). 48% (26/54) of patients live in urban areas, 52% (28/54) in rural areas. Based on bee sting reactions, patients were divided into common localized reactions (32/54), large localized reactions (7/54), and systemic reactions (15/54). In the systemic reaction group, patients presented as Type II (6/15), Type III (6/15). There is significant difference (P < 0.001) between the three groups in regards to exposure types. In the systemic reaction group, 8.7% (13/15) of patients are beekeepers. A significant difference (P < 0.001) was observed between allergic and control groups based on sIgE/T-IgE results. As well as significant difference observed between the systemic reaction group to the other two reaction groups in regards to sIgE/T-IgE results. Six systemic reaction patients presented with large localized reactions before onset of system symptoms 1 month to 1 year of being stung.
CONCLUSIONSOccupational exposure is the most common cause in honeybee venom allergy induced systemic reactions. The use of sIgE/T-IgE results is a useful diagnostic parameter in determining honeybee venom allergy.
Adult ; Bee Venoms ; immunology ; Beekeeping ; China ; Female ; Humans ; Hypersensitivity ; blood ; immunology ; Immunoglobulin E ; blood ; immunology ; Insect Bites and Stings ; immunology ; Male ; Middle Aged ; Occupational Diseases ; Occupational Exposure ; adverse effects ; Retrospective Studies